Non-Performing-Loans (NPL)

Defining the right strategy for non-performing loans or potentially non-performing loans or business areas at an early stage - in an increasingly tense competitive environment and due to ever more complex regulatory requirements, this is becoming more and more of a necessity in the German banking market. Whether internal restructuring or sale on the secondary market, we are happy to advise you on your strategic repositioning. Among other things, we offer you

• Support in the optimal choice of action strategy, taking into account your specific requirements in terms of resources, time and capital
• In-depth insights into the consequences of the strategy for the business unit and the bank as a whole through comprehensive impact and scenario analyses

During the transaction process, we know the requirements and expectations of investors and help you to make the right decisions. In this way, you maximise the results in a potential sales process. Among other things, we offer you

• Coordination of the entire transaction process
• Access to our global investor network and professional approach
• Investor-orientated preparation of loan portfolio documents
• Analysis and quality assurance of the data through the use of innovative tools
• Credit valuations and analysis and preparation of cash flows for an efficient sales process
• Optimised structuring of loan portfolios in terms of type and amount of composition as well as strategic orientation
• Support with contract negotiations

An essential basis for the future success of your business model is to utilise the knowledge gained from successful transactions on a permanent basis. Our support ensures your success by, among other things:

• Establishing new structures to prepare your business model for future transactions
• Developing risk processes for the early identification of non-performing portfolios
• Building and maintaining a sustainable investor network
• Creating incentive systems in front office and control functions to prevent negative effects and risk concentration